Skip to main content
Article thumbnail
Location of Repository

Absence of polysialylated NCAM is an unfavorable prognostic phenotype for advanced stage neuroblastoma

By Miikka Korja, Anne Jokilammi, Toivo T Salmi, Hannu Kalimo, Tarja-Terttu Pelliniemi, Jorma Isola, Immo Rantala, Hannu Haapasalo and Jukka Finne
Topics: Research Article
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles


    1. (1982). Clinical prognostic factors in 1277 patients with neuroblastoma: results of The European Neuroblastoma Study Group 'Survey'
    2. (1991). Expression of the natural killer cell-associated antigens CD56 and CD57 in human neural and striated muscle cells and in their tumors. Cancer Res
    3. (1989). FS: Neural cell adhesion molecule (NCAM) is the antigen recognized by monoclonal antibodies of similar specificity in small-cell lung carcinoma and neuroblastoma.
    4. (1987). Goridis C: Characterization of neural cell adhesion molecules (NCAM) expressed by Ewing and neuroblastoma cell lines.
    5. (1983). Goridis C: Occurrence of alpha 2–8 linked polysialosyl units in a neural cell adhesion molecule. Biochem Biophys Res Commun
    6. (1994). Guild BC: Humanization of murine monoclonal antibodies through variable domain resurfacing.
    7. (1991). Imashuku S: Expression of CD56/NCAM on hematopoietic malignant cells. A useful marker for acute monocytic and megakaryocytic leukemias.
    8. (1988). International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma.
    9. (1991). Kemshead JT: A monoclonal antibody (ERIC-1), raised against retinoblastoma, that recognizes the neural cell adhesion molecule (NCAM) expressed on brain and tumours arising from the neuroectoderm.
    10. (1998). Muntinghe FL: Expression of neural cell adhesion molecules and neurofilament protein isoforms in skeletal muscle tumors. Hum Pathol
    11. (2004). NC: In vitro and in vivo activity of the maytansinoid immunoconjugate huN901-N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine against CD56+ multiple myeloma cells. Cancer Res
    12. (1996). Polysialic acid in the vertebrate nervous system: a promoter of plasticity in cell-cell interactions. Trends Neurosci
    13. (2008). Targeting CD56 by the maytansinoid immunoconjugate IMGN901 (huN901-DM1): a potential therapeutic modality implication against natural killer/T cell malignancy.
    14. (1991). Zandwijk N: Neural cell adhesion molecule expression, neuroendocrine differentiation and prognosis in lung carcinoma.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.